» Articles » PMID: 34568523

Roles of MiR-432 and Circ_0000418 in Mediating the Anti-depressant Action of ADAR1

Overview
Date 2021 Sep 27
PMID 34568523
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Adenosine deaminase acting on RNA1 (ADAR1) is a newly discovered epigenetic molecule marker that is sensitive to environmental stressors. A recent study has demonstrated that ADAR1 affects BDNF expression via miR-432 and is involved in antidepressant action. However, the detailed molecular mechanism is still unclear. We have uncovered a new molecular mechanism showing the involvement of miR-432 and circ_0000418 in mediating the antidepressant action of ADAR1. We demonstrate that the ADAR1 inducer (IFN-γ) alleviates the depressive-like behaviors of BALB/c mice treated with chronic unpredictable stress (CUS) exposure. Moreover, both in vivo and in vitro studies show that ADAR1 differently impacts miR-432 and circ_0000418 expressions. Furthermore, the in vitro results demonstrate that circ_0000418 oppositely affects BDNF expression. Together, our results indicate that ADAR1 affects CUS-induced depressive-like behavior and BDNF expression by acting on miR-432 and circ_0000418. Elucidation of this new molecular mechanism will not only provide insights into further understanding the important role of ADAR1 in stress-induced depressive-like behavior but also suggest a potential therapeutic strategy for developing novel anti-depressive drugs.

Citing Articles

Blood-Based MicroRNAs in Psychotic Disorders-A Systematic Review.

Grosu S, Dobre M, Milanesi E, Hinescu M Biomedicines. 2023; 11(9).

PMID: 37760977 PMC: 10525934. DOI: 10.3390/biomedicines11092536.


The involvement of ADAR1 in chronic unpredictable stress-induced cognitive impairment by targeting DARPP-32 with miR-874-3p in BALB/c mice.

Wang Y, Liu Y, Zhao Z, Wu X, Lin J, Li Y Front Cell Dev Biol. 2023; 11:919297.

PMID: 37123418 PMC: 10132208. DOI: 10.3389/fcell.2023.919297.


Alterations in microRNA of extracellular vesicles associated with major depression, attention-deficit/hyperactivity and anxiety disorders in adolescents.

Honorato-Mauer J, Xavier G, Ota V, Chehimi S, Mafra F, Cuoco C Transl Psychiatry. 2023; 13(1):47.

PMID: 36746925 PMC: 9902559. DOI: 10.1038/s41398-023-02326-4.


Hsa_circ_0000418 promotes the progression of glioma by regulating microRNA-409-3p / pyruvate dehydrogenase kinase 1 axis.

Ma Z, Chen Z, Zhou Y, Li Y, Li S, Wang H Bioengineered. 2022; 13(3):7541-7552.

PMID: 35264067 PMC: 8974101. DOI: 10.1080/21655979.2022.2049027.

References
1.
Ebert M, Sharp P . MicroRNA sponges: progress and possibilities. RNA. 2010; 16(11):2043-50. PMC: 2957044. DOI: 10.1261/rna.2414110. View

2.
Rana T, Behl T, Sehgal A, Srivastava P, Bungau S . Unfolding the Role of BDNF as a Biomarker for Treatment of Depression. J Mol Neurosci. 2020; 71(10):2008-2021. DOI: 10.1007/s12031-020-01754-x. View

3.
Dracheva S, Chin B, Haroutunian V . Altered serotonin 2C receptor RNA splicing in suicide: association with editing. Neuroreport. 2008; 19(3):379-82. DOI: 10.1097/WNR.0b013e3282f556d2. View

4.
Jacobs M, Fogg R, Emeson R, Stanwood G . ADAR1 and ADAR2 expression and editing activity during forebrain development. Dev Neurosci. 2009; 31(3):223-37. PMC: 2692045. DOI: 10.1159/000210185. View

5.
Karpova N . Role of BDNF epigenetics in activity-dependent neuronal plasticity. Neuropharmacology. 2013; 76 Pt C:709-18. DOI: 10.1016/j.neuropharm.2013.04.002. View